- GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung Adenocarcinoma
Jiahui Han et al, 2021, Frontiers in Oncology CrossRef - Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer
Mohamed Haider et al, 2022, International Journal of Molecular Sciences CrossRef - Isothiocyanates (ITCs) 1-(Isothiocyanatomethyl)-4-phenylbenzene and 1-Isothiocyanato-3,5-bis(trifluoromethyl)benzene—Aldehyde Dehydrogenase (ALDH) Inhibitors, Decreases Cisplatin Tolerance and Migratory Ability of NSCLC
Jolanta Kryczka et al, 2022, International Journal of Molecular Sciences CrossRef - Recent advances in the therapeutic potential of emodin for human health
Javad Sharifi-Rad et al, 2022, Biomedicine & Pharmacotherapy CrossRef - Cisplatin in Ovarian Cancer Treatment—Known Limitations in Therapy Force New Solutions
Aleksandra Zoń et al, 2023, International Journal of Molecular Sciences CrossRef - Emerging Nanotechnology-based Therapeutics: A New Insight into Promising Drug Delivery System for Lung Cancer Therapy
Ravinder Verma et al, 2024, Recent Patents on Nanotechnology CrossRef - Combination Anticancer Therapies Using Selected Phytochemicals
Wamidh H. Talib et al, 2022, Molecules CrossRef - Nano-Enabled Strategies for the Treatment of Lung Cancer: Potential Bottlenecks and Future Perspectives
Mohammed Kanan Alshammari et al, 2023, Biomedicines CrossRef - Targeting Drug Chemo-Resistance in Cancer Using Natural Products
Wamidh H. Talib et al, 2021, Biomedicines CrossRef - Structure-Activity Relationship Insight of Naturally Occurring Bioactive Molecules and Their Derivatives Against Non-Small Cell Lung Cancer: A Comprehensive Review
Subham Das et al, 2022, Current Medicinal Chemistry CrossRef - GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma
Shimao Song et al, 2022, Journal of Clinical Laboratory Analysis CrossRef - Is Emodin with Anticancer Effects Completely Innocent? Two Sides of the Coin
Esra Küpeli Akkol et al, 2021, Cancers CrossRef - The Health Benefits of Emodin, a Natural Anthraquinone Derived from Rhubarb—A Summary Update
Monika Stompor-Gorący, 2021, International Journal of Molecular Sciences CrossRef - Emodin Ameliorates the Efficacy of Carfilzomib in Multiple Myeloma Cells via Apoptosis and Autophagy
Chin-Mu Hsu et al, 2022, Biomedicines CrossRef - Targeting Apoptotic Pathway of Cancer Cells with Phytochemicals and Plant-Based Nanomaterials
Atif Khurshid Wani et al, 2023, Biomolecules CrossRef - Cisplatin for cancer therapy and overcoming chemoresistance
Ranmali Ranasinghe et al, 2022, Heliyon CrossRef - The ethyl acetate extract of Wenxia Changfu Formula inhibits the carcinogenesis of lung adenocarcinoma by regulating PI3K-AKT signaling pathway
Lei Wang et al, 2023, Scientific Reports CrossRef - Unraveling the pulmonary drug delivery carriers in inhalable nanostructures
Zhengwei Huang et al, 2022, Journal of Nanoparticle Research CrossRef - Advances in the pharmacological effects and molecular mechanisms of emodin in the treatment of metabolic diseases
Linyuan Yu et al, 2023, Frontiers in Pharmacology CrossRef - CK2α/CSNK2A1 Induces Resistance to Doxorubicin through SIRT6-Mediated Activation of the DNA Damage Repair Pathway
Usama Khamis Hussein et al, 2021, Cells CrossRef - Enhancement of cisplatin-induced apoptosis by saffron in human lung cancer cells
Zeinab Mokhtari et al, 2023, Journal of Trace Elements in Medicine and Biology CrossRef - Pan-cancer analysis identified OAS1 as a potential prognostic biomarker for multiple tumor types
Shan Jiang et al, 2023, Frontiers in Oncology CrossRef